financetom
Business
financetom
/
Business
/
Fennec Pharmaceuticals Signs Exclusive Licensing Deal With Norgine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fennec Pharmaceuticals Signs Exclusive Licensing Deal With Norgine
Mar 18, 2024 2:54 AM

05:32 AM EDT, 03/18/2024 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) and Norgine said Sunday that they have signed an exclusive licensing agreement to commercialize Pedmarqsi, which is intended for the prevention of hearing loss induced by cisplatin chemotherapy in patients one month to less than 18 years old with localized, non-metastatic solid tumors.

Under the agreement, Norgine will commercialize the drug in Europe, Australia and New Zealand. In exchange, Fennec will receive 40 million euros ($43.6 million) in upfront payment and up to 210 million euros in additional commercial and regulatory milestone payments, plus royalties on product sales.

Norgine will be responsible for all commercialization activities in the licensed areas and will hold all marketing authorization in them, the companies said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Edwards Lifesciences Insider Sold Shares Worth $327,843, According to a Recent SEC Filing
Edwards Lifesciences Insider Sold Shares Worth $327,843, According to a Recent SEC Filing
Nov 13, 2024
06:23 PM EST, 11/13/2024 (MT Newswires) -- Donald E Bobo Jr., CVP, Strategy Development, on November 13, 2024, sold 5,000 shares in Edwards Lifesciences ( EW ) for $327,843. Following the Form 4 filing with the SEC, Bobo has control over a total of 220,704 shares of the company, with 46,936 shares held directly and 173,769 controlled indirectly. SEC Filing:...
Ameriprise Financial Insider Sold Shares Worth $4,882,780, According to a Recent SEC Filing
Ameriprise Financial Insider Sold Shares Worth $4,882,780, According to a Recent SEC Filing
Nov 13, 2024
06:19 PM EST, 11/13/2024 (MT Newswires) -- Walter Stanley Berman, Executive VP and CFO, on November 11, 2024, sold 8,655 shares in Ameriprise Financial ( AMP ) for $4,882,780. Following the Form 4 filing with the SEC, Berman has control over a total of 6,769 shares of the company, with 6,409 shares held directly and 360 controlled indirectly. SEC Filing:...
Schlumberger Insider Sold Shares Worth $512,294, According to a Recent SEC Filing
Schlumberger Insider Sold Shares Worth $512,294, According to a Recent SEC Filing
Nov 13, 2024
06:20 PM EST, 11/13/2024 (MT Newswires) -- Stephane Biguet, EVP & CFO, on November 13, 2024, sold 11,520 shares in Schlumberger ( SLB ) for $512,294. Following the Form 4 filing with the SEC, Biguet has control over a total of 191,556 shares of the company, with 191,556 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/87347/000112760224027250/xslF345X05/form4.xml Price: 39.80, Change: +0.04, Percent Change:...
EXP World Holdings Insider Sold Shares Worth $351,353, According to a Recent SEC Filing
EXP World Holdings Insider Sold Shares Worth $351,353, According to a Recent SEC Filing
Nov 13, 2024
06:21 PM EST, 11/13/2024 (MT Newswires) -- James Bramble, Chief Legal Counsel, on November 13, 2024, sold 25,000 shares in eXp World Holdings ( EXPI ) for $351,353. SEC Filing: https://www.sec.gov/Archives/edgar/data/1495932/000156218024007678/xslF345X05/primarydocument.xml Price: 13.86, Change: -0.06, Percent Change: -0.43 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved